Acquired Immunodeficiency Syndrome: all 3,037 studies

Page 18 of 31. Open to participants first (307), then studies with results posted, then the rest; newest registration first within each.

• Hybrid STTR Intervention for Heterosexuals: Anonymous Testing and Confidential Care LinkageCompletedNCT02421159Not applicable
• Effect of Rifampin (RIF) on the Pharmacokinetics (PK) of Oral Cabotegravir (CAB) in Healthy SubjectsCompletedNCT02411435Phase 1
• Clinical Implications of HIV Low-level Viremia at Times of Highly Active Antiretroviral Treatment RegimensStatus unknownNCT02411071
• Collaborative Care for the Detection and Management of Depression Among Adults Receiving Antiretroviral Therapy in South AfricaCompletedNCT02407691Not applicable
• Evaluating a Microfinance Intervention for Vulnerable Women in KazakhstanCompletedNCT02406482Not applicable
• Jamii Bora: A Home-Based Couples InterventionCompletedNCT02403583Not applicable
• The Dolutegravir Antiretroviral Mono-Therapy for HIV TrialCompletedNCT02401828Phase 4
• Pericardial Fat and Inflammation in HIV Patients and ControlsCompletedNCT02399384
• Intervention of HIV, Drug Use and the Criminal Justice System in MalaysiaCompletedNCT02396979Phase 4
• Accuracy Evaluation of the BD FACS Presto SystemCompletedNCT02396355
• Cognitive-Based Compassion Training (CBCT) for People Living With HIV (PLHIV)CompletedNCT02395289Not applicable
• HIV Medication Adherence in Underserved PopulationsStatus unknownNCT02392884Not applicable
• Simplifying the Shang Ring Technique for Circumcision of Men and BoysCompletedNCT02390310Not applicable
• A Phase I Study of T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728mR in HIV-Infected PatientsCompletedNCT02388594Phase 1
• Safety and Immunogenicity Study of a DNA Vaccine Combined With Protein Vaccine Against HIV/AIDSCompletedNCT02376582Phase 1
• Relative Oral Bioavailability Study of Different Fixed Dose Combinations of Dolutegravir and Rilpivirine in Healthy SubjectsCompletedNCT02373930Phase 1
• Test Albuvirtide in Experienced PatientsCompletedNCT02369965Phase 3
• HIV & Drug Abuse Prevention for South African MenCompletedNCT02358226Phase 3
• Pharmacokinetics Study of GSK1265744 in Subjects With Severe Renal ImpairmentCompletedNCT02354937Phase 1
• Pharmacokinetics of Lopinavir/Ritonavir Superboosting in Infants and Young Children Co-infected With HIV and TBCompletedNCT02348177Phase 4
• Safety and Pharmacokinetic Study of Oral Maraviroc and Maraviroc 1% Gel in HIV-1 Seronegative AdultsCompletedNCT02346084Phase 1
• Relative Bioavailability Study of Phase III Tablet Formulation of CabotegravirCompletedNCT02345707Phase 1
• Accuracy of Portable Colposcopy and HPV Genotypes Among HIV+ WomenTerminatedNCT02338141Not applicable
• Immune Recovery in Advanced , ARV-naïve, HIV-1-infected Individuals Taking Dolutegravir or Ritonavir-boosted DarunavirStatus unknownNCT02337322Phase 4
• Male Circumcision Services for HIV Prevention in the Dominican RepublicCompletedNCT02337179Not applicable
• Vietnam Cryptococcal Retention in Care Study Version 1.0Status unknownNCT02334670
• Adherence & Health Outcome Differences Amongst HIV Infected Patients Prescribed HAARTCompletedNCT02322827
• Alendronate for Prevention of AntiRetroviral Therapy-associated Bone LossTerminatedNCT02322099Phase 4
• Strategies for the Prevention of Hepatitis B Among HIV Infected Patients in UgandaCompletedNCT02316444Phase 4
• Using Cultural Ceremonies to Reduce Intimate Partner Violence and HIV TransmissionCompletedNCT02311699Not applicable
• Effectiveness of Peer Navigation and Contingency Management on Retention in HIV CareCompletedNCT02310893Not applicable
• Safety, Tolerability and Immunogenicity Study of 2 Dose Levels of Trimeric Glycoprotein140 (gp140) in Healthy Adult VolunteersCompletedNCT02304185Phase 1
• Tele-IPT for HIV-Infected Rural PersonsCompletedNCT02299453Phase 1/2
• REMUNE HIV/AIDS Vaccine Phase II Pediatric Safety & Efficacy Clinical StudyStatus unknownNCT02291809Phase 2
• A Prospective Observational Trial to Determine Cardiovascular Diseases in HIV-infected PatientsCompletedNCT02291081
• A Repeat Dose Pharmacokinetic (PK) and Safety Study of GSK2838232 With and Without Ritonavir (RTV) Conducted in Healthy SubjectsTerminatedNCT02289495Phase 1
• A Single Dose Pharmacokinetic (PK) and Safety Study of GSK2838232 With and Without Ritonavir (RTV) Conducted in Healthy SubjectsTerminatedNCT02289482Phase 1
• Pharmacokinetics of Once Daily Darunavir/Ritonavir in HIV-infected ChildrenCompletedNCT02285478
• Facilitating HIV/AIDS and HIV Testing Literacy for Emergency Department PatientsStatus unknownNCT02284451Not applicable
• Feasibility Study of PrePex Device When Performed on Early Infants & Children Male Population by PhysiciansCompletedNCT02281461Not applicable
• A Phase 1 Antiretroviral Drug-Drug Interaction Study in Healthy Volunteers (DDI)CompletedNCT02277600Phase 1
• Food Effect Study With BMS-955176CompletedNCT02273947Phase 1
• Exploring Novel Mechanisms of Vaccine Failure LAIV Pilot StudyCompletedNCT02266992Phase 2
• Peripheral Arterial Insufficiency Associated With HIV/AIDSCompletedNCT02264509
• Phase II Motivational Interviewing: An Experiential Online Training ToolCompletedNCT02264327Not applicable
• Study on the Impact of Patient Navigators on the Health Education and Quality of Life in Formerly Incarcerated PatientsTerminatedNCT02259634Not applicable
• RCT of CBT for Insomnia With PLWHACompletedNCT02259101Not applicable
• Improving Cervical Cancer Screening Among HIV-Infected Women in IndiaCompletedNCT02247999
• The Effects of Statin Therapy on Coronary Flow Reserve and Inflammatory Markers in HIV-Positive PatientsCompletedNCT02234492Phase 4
• Early cART and cART in Combination With Autologous HIV-1 Specific Cytotoxic T Lymphocyte (CTL) Infusion in The Treatment of Acute HIV-1 Infected AdultsStatus unknownNCT02231281Phase 3
• Early Phase Evaluation of ABC294640 in Patients With Refractory/Relapsed Diffuse Large B-cell Lymphoma or Kaposi SarcomaWithdrawnNCT02229981Phase 1/2
• Reducing Proviral HIV DNA With Interferon-aStatus unknownNCT02227277Phase 2
• A Phase I Study of an HIV Vaccine in Healthy, HIV Uninfected AdultsCompletedNCT02218125Phase 1
• Effects of Facility-based Mother Support Groups on Prevention of mother-to Child Transmission Outcomes in ZimbabweStatus unknownNCT02216734Not applicable
• The Effect of an Enhanced Rice Bran Nutritional Supplement in HIVCompletedNCT02214173Not applicable
• The Tolerability of, and Adherence to, Dolutegravir With Co-formulated Tenofovir-emtricitabine for HIV Non-occupational Post-exposure ProphylaxisCompletedNCT02211690Phase 4
• Hepatic Safety of Eviplera® in HIV/Hepatitis C (HCV)-Coinfected Patients Without HCV Treatment in the "The HEPAVIR HEPATIC SAFETY Cohort."CompletedNCT02196064
• Clinical and Therapeutic Evaluation of the Infection by HIV/AIDSCompletedNCT02191215
• A Study to Assess the Long-term Safety and Tolerability of TMC114/Rtv in HIV-1 Infected Participants After Rolling-over From Other TMC114 TrialsCompletedNCT02187107Phase 2
• Bioavailability Study of a Dolutegravir Dispersible Tablet and Effect of Different Types of Water on the Dispersible Tablet in Healthy VolunteersCompletedNCT02185300Phase 1
• DuoPACT Pilot InterventionCompletedNCT02181881Not applicable
• Increasing Social Support to Improve HIV Care Engagement and Adherence in St. Petersburg, RussiaCompletedNCT02167828Not applicable
• PrEPared and Strong: Clinic-Based PrEP for Black MSMCompletedNCT02167386Phase 4
• Nevirapine Dosing in Neonates for Prophylaxis of Mother-to-Child-Transmission (MTCT) of HIV InfectionCompletedNCT02166502
• Study to Determine the Effect of Efavirenz on the ECG QTcF Interval in Healthy SubjectsCompletedNCT02164812Phase 1
• Study to Evaluate the Effect of Food on the Pharmacokinetics of BMS-626529CompletedNCT02164045Phase 1
• Zinc Supplementation Effect on Immune Recovery in HIV PatientsStatus unknownNCT02162797Not applicable
• Study to Evaluate the Pharmacokinetics of an Oral Contraceptive Containing Levonorgestrel and Ethinyl Estradiol When Co-administered With GSK1265744 in Healthy Adult Female SubjectsCompletedNCT02159131Phase 1
• Maraviroc and NeuroAIDS PathogenesisCompletedNCT02159027Phase 2/3
• Study of Combined Oral Contraceptive Effects in Female SubjectsCompletedNCT02157467Phase 1
• An Open Label, Blinded Assessor, Trial Comparing Odor Levels Due to Different Hygiene Methods With PrePexTMCompletedNCT02153658Not applicable
• PRe-Exposure Prophylaxis Acceptability & Readiness Assessments for Toronto gaY, Bisexual and Other Men Who Have Sex With Men-5CompletedNCT02149888Phase 4
• Demonstrating Safety and Effective Delivery of Daily Oral Pre-exposure Prophylaxis (PrEP) for Sex Workers in IndiaCompletedNCT02148094Early Phase 1
• COMO: Cognition Study With HIV+ Patients (CTNPT 015)TerminatedNCT02144688Early Phase 1
• DASH - Decision Making in Adolescent Sexual HealthTerminatedNCT02141646Not applicable
• Drug-drug Interaction (DDI) RifabutinCompletedNCT02138084Phase 1
• Relationship of Tenofovir With HIV-1 Suppression in ex Vivo Tissue in AdolescentsCompletedNCT02134431
• Improving Drug Adherence Among Adolescents in Uganda Using SMS RemindersCompletedNCT02128087Not applicable
• Adolescent Master Protocol for Participants 18 Years of Age and Older (AMP Up)CompletedNCT02119702
• Medication Adherence in Human Immunodeficiency Virus (HIV)CompletedNCT02119390Not applicable
• Antiretroviral Adherence and Quality-of-life Support for HIV+ Patients in India With Twice-daily Interactive Voice Response (IVR) Calls With Health and Mental Health Messaging Compared to Weekly IVR Survey Only Control Condition: The Mobile-messaging Adherence and Support for Health Study, India.CompletedNCT02118454Not applicable
• DVD-based HIV/HCV Prevention Intervention for Drug-Involved Latino Criminal Justice ClientsCompletedNCT02116179Not applicable
• Score System for Prediction Risk and Early Diagnosis of HCC in HIV/HCV PatientsCompletedNCT02113865
• Safety & Immunogenicity of HIV Vaccines in Healthy Kenyan AdultsCompletedNCT02099994Phase 1/2
• Clinical Outcomes of Cryptococcal Meningitis Among HIV-infected Patients in the Era of Antiretroviral TherapyCompletedNCT02098525
• Relative Bioavailability Study With BMS-955176CompletedNCT02095886Phase 1
• Study to Evaluate the Drug Interaction Between Dolutegravir (DTG) and Daclatasvir (DCV) in Healthy Adult SubjectsCompletedNCT02082808Phase 1
• A Prospective, Non-interventional Study of the Use of Dolutegravir as Part of Combination Antiretroviral Therapy in Routine Daily Practice in GermanyCompletedNCT02076386
• Effects of an HIV Intervention Among Sex Workers in the PhilippinesCompletedNCT02071264Not applicable
• Does Provision of Point of Care CD4 Technology and Early Knowledge of CD4 Levels Affect Early Initiation and Retention on Anti-retroviral Treatment (ART) in HIV Positive Pregnant Women in the Context of Option B+ for PMTCT?Status unknownNCT02070900Not applicable
• Effect of Dolutegravir on Metformin Pharmacokinetics in Healthy Adult SubjectsCompletedNCT02064374Phase 1
• DDI Study of BMS-663068 With Etravirine (ETR) and/or Darunavir (DVR) + Ritonavir (RTV)CompletedNCT02063360Phase 1
• CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell TransplantActive, not recruitingNCT02061800Phase 1/2
• A Study to Assess The Relative Bioavailability of New Tablet Formulations of GSK1265744 in Healthy Adult SubjectsCompletedNCT02059031Phase 1
• Real-life Security and Efficacy of DAA-based Therapy in HCV/HIV-Coinfected PatientsStatus unknownNCT02057003
• HIV Clinic-Based Intervention to Improve ART Adherence and Prevent HIV TransmissionCompletedNCT02044484Not applicable
• Pediatric Enhanced Surveillance StudyCompletedNCT02043769
• Healthy Options: Group Psychotherapy for HIV-positive Depressed Perinatal Women.CompletedNCT02039973Not applicable
• Intervention to Enhance PrEP Uptake and Adherence in a Community-Based SettingCompletedNCT02037594Not applicable
• Assessment of Group Peer Support to Children With HIV in VietnamStatus unknownNCT02035969Not applicable

← Acquired Immunodeficiency Syndrome overview